HealthWell Foundation: MASH

Coverage RequiredFunded

About

The HealthWell Foundation MASH Fund provides up to $8,000 in copay or insurance premium assistance for patients prescribed qualifying medications including Wegovy. Average utilization is $3,100 per 12-month grant period. Income limit is 500% FPL. Fund is currently OPEN. Also covers related medical costs including labs, imaging, liver biopsy, hepatologist visits, and transportation.

Insurance requirements: Commercially Insured, Medicare / Medicaid

Enrollment Forms

HealthWell Foundation MASH Fund

Benefits

•$8000 annual maximum benefit

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: Yes

•Needs Based: Yes

•Activation Required: No

Program Details

•Maximum award up to $8,000 per 12month grant period

•Average patient utilization: $3,100 per grant period

•Covers prescription drug copays and Medicare Part B premiums

•Payment via pharmacy card

•Income eligibility: household income at or below 500% Federal Poverty Level

•Must have insurance that covers the qualifying medication

•Accepts commercially insured and governmentinsured patients

•Fund status: OPEN currently accepting new applications

•Also covers: Ozempic, Rybelsus, Rezdiffra, Saxenda, Victoza

•Additional coverage: lab work, imaging (CT, MRI, ultrasound), liver biopsy, hepatologist visits, transportation costs

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Enrollment Forms

HealthWell Foundation MASH Fund

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Frequently Asked Questions (FAQ)

The Wegovy Savings Offer from Novo Nordisk lets eligible commercially insured patients pay as little as $25 per month, with savings up to $100 per month. Patients with Medicare or Medicaid coverage can't use the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH programs (Wegovy at no cost, eligibility-dependent). Open the program cards above for the option that matches your patient.

Yes — the Wegovy Savings Offer from Novo Nordisk. Eligible patients with commercial insurance pay as little as $25 per month, up to $100 per month in savings. Patients on Medicare or Medicaid aren't eligible for the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH program (Wegovy at no cost for eligible patients). See the program cards above for current terms.

PrescriberPoint surfaces Novo Nordisk's self-pay options for uninsured patients: the Wegovy Self-Pay Program for the oral tablet is as low as $149 per month, and the injectable self-pay program is as low as $349 per month. Commercially insured patients can use the Wegovy Savings Offer instead — as little as $25 per month, up to $100 per month in savings. Open the program cards above to compare every option for your patient.

There are paths for every coverage type. Commercially insured patients → Wegovy Savings Offer ($25/month, up to $100/month in savings). Medicare or Medicaid patients → HealthWell Foundation MASH or PAN Foundation MASH (no cost for eligible patients). Uninsured patients → Wegovy Self-Pay Program ($149/month oral tablet, $349/month injectable). The program cards above show each option with its eligibility and enrollment link.